News
Uncertainty loomed as FDA advisors met to discuss this year’s COVID shot
Expert advisors for the Food and Drug Administration met Thursday to discuss which virus strain this year's updated COVID-19 vaccines should target. The advisors have been meeting around this time each year for such a strain selection,
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in ...
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and, in most cases, resolve within a ...
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback